This Biotech ETF Doesn't Need Coronavirus Vaccines to Soar

By: ETFdb
In the world of biotechnology stocks and ETFs, investors are pumping up those names with exposure to coronavirus treatments and vaccines. However, the ALPS Medical Breakthroughs ETF ( SBIO ) shouldn’t be forgotten in all that commotion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.